National Institute of Standards and Technology / NIH Center / Rutgers University / Coriell Institute / University of Wisconsin-Madison / /
IndustryTerm
ad hoc solutions / media formulation / clinical applications / equivalent product / university technology transfer offices / biotechnology / on university technology transfer offices / end product / chemical compounds / requisite technology / marketable product / comfortable solution / pharmaceutical / stem cell biotechnology / given product / media formulations / particular technology / Technology cycles / biotechnology field / biotechnology licensing infrastructure / biotechnology industry / technology changes / technology / tissue banks / therapeutic solutions / license technology / patent law / software industry / university biotechnology nexus / Technology transfer offices / biotechnology sectors / biotechnology incubators / biotechnology sector / manufacturing organizations / ad hoc solution / /
MedicalCondition
JE / MS / /
MedicalTreatment
antibiotics / gene therapy / cell therapy / /
Movie
City of Hope / /
Organization
National Institute of Health / National Science Foundation / US Patent and Trademark Office / Rutgers University / Harvard / NIH Center for Regenerative Medicine / Wisconsin Alumni Research Foundation / NIH CRM / Coriell Institute / National Institute of Standards and Technology / European Chemical Agency / Common Fund / US Food and Drug Administration / Department of Defense / University of Wisconsin / Stanford / Environmental Protection Agency / /
Person
Rao Abstract / Pat Regen Med / Megan Laycock / Steven Becker / /
Position
investigator / important driver / selfsustaining model for reinvestment / Tereskerz PM / author / writer / individual investigator / /
Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome